share_log

泽璟制药(688266.SH):上半年净亏损6653.6万元 同比减亏

Zejing Pharmaceuticals (688266.SH): a net loss of 66.536 million yuan in the first half of the year, a decrease in losses compared to the same period last year.

Gelonghui Finance ·  Aug 23 04:44

On August 23, Zijing Pharmaceutical (688266.SH) released its semi-annual report, with revenue of 0.24 billion yuan, a year-on-year growth of 9.44%. The net loss was 66.536 million yuan, a decrease in losses compared to the previous year, and a non-GAAP net loss of 72.37 million yuan, a decrease in losses compared to the previous year. The basic earnings per share was -0.25 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment